News Release

In wake of Flint crisis, new proposal seeks to 'focus on the fix' for lead poisoning

Leading expert outlines three-point plan to eliminate lead

Peer-Reviewed Publication

Wolters Kluwer Health

May 27, 2016 - The crisis of lead-contaminated drinking water in Flint, Mich., continues to make headlines--but it's just the most prominent example of an "ongoing and needless tragedy of childhood lead poisoning," according David E. Jacobs, PhD, CIH, a noted authority on childhood lead poisoning prevention. Dr. Jacobs writes in the June Journal of Public Health Management and Practice, published by Wolters Kluwer.

The "debacle" in Flint should spur urgently needed but long-delayed action to address the continuing crisis of lead poisoning in the United States and around the world, says Dr. Jacobs, Chief Scientist at the National Center for Healthy Housing, Columbia, Md, and adjunct professor at the University of Illinois at Chicago School of Public Health. He proposes a three-point plan to identify and eliminate sources of lead exposure nationwide.

Three-Point Plan for Eliminating Lead: 'Find It, Fix It, Fund It'

Two new studies, also in the June issue of JPHMP, illustrate the deficiencies of current childhood blood lead screening programs and housing code processes that ignore lead poisoning and other chronic health issues. "Together, both articles demonstrate the need for more robust and effective responses to lead poisoning, which causes 675,000 deaths around the globe," Dr. Jacobs writes. He adds that at least 535,000 US children have elevated blood lead levels.

As the nation seeks answers about what happened in Flint, Dr. Jacobs believes a critical question has gone unasked: "How did that lead get into our pipes and our paint in the first place?" He points out that industrial groups and paint companies continue not only to make lead-containing products, but also to block public health efforts to stop these sources of lead contamination. "Those 'normal business operations' mean that these companies continue to make new lead-based paint in other countries, contaminating even more homes," according to the author.

Dr. Jacobs notes that, in 2000, he helped to craft a Presidential task force plan that would have eliminated lead hazards by 2010. "But Congress never funded it adequately, and as a direct result, the problem has dragged on needlessly, with much higher costs for property maintenance, special education, crime, health care, litigation--and, of course, human suffering."

In his commentary, Dr. Jacobs outlines a three-point plan that "focuses on the fix" for childhood lead poisoning--identifying and eliminating all sources of lead exposure:

  • Find It. Comprehensive programs are needed to increase testing for lead in homes and pipes, as well as expanded screening of children at risk--especially among Medicaid-eligible children. Dr. Jacobs calls for adequate funding and staffing for effective efforts in every state and large city. He emphasizes the inadequacy of the current "medical model"--in which lead-exposed children aren't identified until after they have been poisoned.

  • Fix It. Once lead hazards have been identified, corrective action needs to be taken immediately using proven interim methods. In addition, long-term full-scale programs are needed to eliminate all lead drinking-water pipes and all residential lead paint from the US housing stock. Dr. Jacobs also highlights the need for special education assessment and programs for lead-poisoned children.

  • Fund It. Dr. Jacobs also calls for accountability for companies that have continued to produce lead-contaminated products, long after the hazards were recognized. He writes, "Industry must help pay to help fix the problem, not just pay their lawyers to drag out court cases for decades and overturn verdicts that have held them accountable." He makes the case that fixing lead hazards is an "economically sound" investment, with a cost-effectiveness even higher than that of childhood vaccines. He also calls on Congress to end the disinvestment in communities and to appropriate the necessary funding.

Dr. Jacobs urges public and environmental health professionals, engineers, and housing professionals to insist on the necessary funding and effort to meet the continuing challenge of lead poisoning. He concludes, "As the nation increasingly turns to its public health professionals for answers, we must speak clearly and forcefully, communicate accurately based on what the science tells us, focus on securing resources needed for solutions, and then make sure that both short and long-term fixes are really working."

###

Click here to read "Lead Poisoning: Focusing on the Fix."

Article: "Lead Poisoning: Focusing on the Fix" (doi: 10.1097/PHH.0000000000000430)

About Journal of Public Health Management and Practice

Journal of Public Health Management and Practice publishes articles which focus on evidence based public health practice and research. The journal is a bi-monthly peer-reviewed publication guided by a multidisciplinary editorial board of administrators, practitioners and scientists. Journal of Public Health Management and Practice publishes in a wide range of population health topics including research to practice; emergency preparedness; bioterrorism; infectious disease surveillance; environmental health; community health assessment, chronic disease prevention and health promotion, and academic-practice linkages.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit http://www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.